University of North Carolina at Chapel Hill /ID# 274800 — Chapel Hill, North Carolina

University of North Carolina at Chapel Hill /ID# 274800 is a clinical research site located in Chapel Hill, North Carolina, United States 27599-0001.

Crixeo Clinical Trials Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

University of North Carolina at Chapel Hill /ID# 274800 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Autosomal Dominant Polycystic Kidney Disease.

Sponsors: Calico Life Sciences LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chapel Hill

Browse all research sites in North Carolina · View every site in Chapel Hill

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of North Carolina at Chapel Hill /ID# 274800?

University of North Carolina at Chapel Hill /ID# 274800 has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of North Carolina at Chapel Hill /ID# 274800 conducted?

University of North Carolina at Chapel Hill /ID# 274800 has 1 clinical trials on record, with 1 currently active. Their work covers Autosomal Dominant Polycystic Kidney Disease.

Is University of North Carolina at Chapel Hill /ID# 274800 accredited by Crixeo Clinical Trials?

University of North Carolina at Chapel Hill /ID# 274800 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of North Carolina at Chapel Hill /ID# 274800?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.